BIOCREDE INC.

Medtech · Private

Wireless nitric oxide-releasing intravascular catheter with continuous lactate sensor for ICU monitoring

biocrede.com →
Grants
$6.0M
8 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
9
3 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Advanced Nitric Oxide Release Bactericidal Urinary Catheters$869,729
Federal grantDepartment of Health and Human Services · Phase II · Advanced Nitric Oxide Release Bactericidal Urinary Catheters$1,399,893
Federal grantDepartment of Health and Human Services · Phase I · Bactericidal Intravascular Biosensor for Continuous Reading of Lactate in the ICU$202,109
Federal grantDepartment of Health and Human Services · Phase I · Bactericidal Intravascular Biosensor for Continuous Reading of Lactate in the ICU$202,109
Federal grantDepartment of Health and Human Services · Phase II · Advanced Nitric Oxide Release Bactericidal Urinary Catheters$530,164
Federal grantDepartment of Health and Human Services · Phase II · Bactericidal Intravascular Biosensor for Continuous Reading of Lactate in the lCU Ph2$760,088
Federal grantDepartment of Health and Human Services · Phase II · Bactericidal Intravascular Biosensor for Continuous Reading of Lactate in the lCU Ph2$1,377,585
Federal grantDepartment of Health and Human Services · Phase II · Bactericidal Intravascular Biosensor for Continuous Reading of Lactate in the lCU Ph2$617,497
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1420Vitranu, Inc.—$1.5M
1421Ozette Technologies, Inc.—$5.8M
1422NEOVIEW, INC.——
1423BIOCREDE INC.——
1424ALBUS IMAGING LLC——
1425LCD NANOTECH LLC——
1426DIASCOPIC, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 9
  • Device For Providing Therapeutic Gasgranted
  • Medical Products And Methods Configured For Controlled Release Of Nitric Oxidegranted
  • Medical Device With Integrated Biosensorgranted
  • Method Of Making Thromboresistant/bactericidal S-nitroso-n-acetylpenicillamine (snap)-impregnated Nitric Oxide Release Polymers With Enhanced Stabilityapplication
  • Medical Device With Integrated Biosensorapplication
  • Method Of Making Thromboresisttant/ Bactericidal S-nitroso-n-acetylpenicillamine (snap)-impregnated Nitric Oxide Release Polymers With Enhanced Stabilityapplication
  • Device For Providing Therapeutic Gasapplication
  • Medical Products And Methods Configured For Controled Release Of Nitric Oxideapplication
  • Nitric Oxide Releasing Bactericidal and Anti-thrombotic Medical Containment Via Nitric Oxide Donors in Woven Materials and Powdered Compositesapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.